爱博医疗(688050.SH)：目前，公司已在香港和瑞士设立境外子公司

Core Viewpoint - The company emphasizes internationalization as a key strategy, aiming to enhance its presence in overseas markets where its market share is currently low [1] Group 1: International Expansion Strategy - The company is accelerating its overseas market layout by establishing subsidiaries in Hong Kong and Switzerland to support product development and commercialization [1] - The company has obtained product registration certificates in multiple countries and regions, facilitating its international market entry [1] Group 2: Sales and Management - The company is forming its own international sales team and strengthening the management and assessment of its agents to enhance market sales [1]